354 related articles for article (PubMed ID: 14614604)
1. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
[TBL] [Abstract][Full Text] [Related]
2. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
Liang TJ; Hasegawa K; Rimon N; Wands JR; Ben-Porath E
N Engl J Med; 1991 Jun; 324(24):1705-9. PubMed ID: 2034247
[TBL] [Abstract][Full Text] [Related]
3. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis.
Ehata T; Omata M; Chuang WL; Yokosuka O; Ito Y; Hosoda K; Ohto M
J Clin Invest; 1993 Mar; 91(3):1206-13. PubMed ID: 8450049
[TBL] [Abstract][Full Text] [Related]
4. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.
Lindh M; Horal P; Dhillon AP; Furuta Y; Norkrans G
Hepatology; 1996 Sep; 24(3):494-501. PubMed ID: 8781313
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
7. Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.
Nishizono A; Kohno K; Takita-Sonoda Y; Hiraga M; Terao H; Fujioka T; Nasu M; Mifune K
J Med Virol; 1997 Nov; 53(3):266-72. PubMed ID: 9365894
[TBL] [Abstract][Full Text] [Related]
8. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.
Omata M; Ehata T; Yokosuka O; Hosoda K; Ohto M
N Engl J Med; 1991 Jun; 324(24):1699-704. PubMed ID: 2034246
[TBL] [Abstract][Full Text] [Related]
10. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of natural occurrence of two closely linked HBV precore predominant mutations.
Yuan TT; Faruqi A; Shih JW; Shih C
Virology; 1995 Aug; 211(1):144-56. PubMed ID: 7645207
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B virus mutants--clinical significance].
Blum HE; Moradpour D; vøn Weizsäcker F; Wieland S; Peters T; Rasenack JW
Z Gastroenterol; 1997 May; 35(5):347-55. PubMed ID: 9265394
[TBL] [Abstract][Full Text] [Related]
13. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease.
Günther S; Baginski S; Kissel H; Reinke P; Krüger DH; Will H; Meisel H
Hepatology; 1996 Oct; 24(4):751-8. PubMed ID: 8855172
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation.
Sterneck M; Günther S; Santantonio T; Fischer L; Broelsch CE; Greten H; Will H
Hepatology; 1996 Aug; 24(2):300-6. PubMed ID: 8690396
[TBL] [Abstract][Full Text] [Related]
15. The role of HBV DNA and liver histopathology in HBsAg carriers.
Agalar C; Diri C; Usubütün S; Agalar F; Türkyïlmaz R
Hepatogastroenterology; 1997; 44(16):1196-9. PubMed ID: 9261624
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.
Tsai SL; Liaw YF; Yeh CT; Chu CM; Kuo GC
Hepatology; 1995 Apr; 21(4):908-12. PubMed ID: 7535736
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
[No Abstract] [Full Text] [Related]
18. Rare pre-core stop-codon mutant nt. 1897 predominates over wide-spread mutant nt. 1896 in an unusual course of chronic hepatitis B.
Protzer U; Trippler M; Ohl J; Knolle P; Duchmann R; Meyer zum Büschenfelde KH; Gerken G
J Viral Hepat; 1996 May; 3(3):155-62. PubMed ID: 8871875
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus carrier with low titer of antibody to hepatitis B core antigen.
Naito M; Matsuda H; Okuno H; Kim H; Azuma M; Kashiwagi T; Mitsutani N; Koizumi T; Kawaguchi G; Kobayashi Y
Hepatogastroenterology; 1994 Jun; 41(3):235-8. PubMed ID: 7959545
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B virus markers in the internist's practice].
Ivashkin VT; Khazanov AI; Ivlev AS; Vasil'eva AP; Rumiantsev ON; Krivoruchko VA; Lytsar' BN; Izgorodin AS
Klin Med (Mosk); 1991 Sep; 69(9):51-4. PubMed ID: 1803151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]